Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids.
Third cranial nerve palsy is rare in neurocysticercosis and is usually caused by supratentorial or sub-arachnoid lesions with accompanying hydrocephalus or meningitis. We report a patient who presented with third cranial nerve palsy caused by neurocysticercosis involving the midbrain. The patient showed repeated exacerbation of symptoms on tapering corticosteroids. The experience with this patient indicates that tapering of corticosteroids should be performed very slowly in such cases.
Kim
Ji Soo
JS
Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 300 Gumi-Dong, Dundang-Su, Seongnam-Si, Gyeonggi-Do 463-707, Korea. jisookim@snu.ac.kr
Jeong
Seon-Mi
SM
Moon
So Young
SY
Park
Seong-Ho
SH
D000818:Animals; D000913:Antibodies, Protozoan / Q000134:cerebrospinal fluid; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D001763:Blepharoptosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002555:Cerebrospinal Fluid / Q000276:immunology; D003552:Cysticercus / Q000276:immunology; D004172:Diplopia / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008636:Mesencephalon / Q000473:pathology*; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D020019:Neurocysticercosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015840:Oculomotor Nerve Diseases / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D011223:Praziquantel / Q000008:administration & dosage; D012008:Recurrence
D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D005938:Glucocorticoids; D011223:Praziquantel; D008775:Methylprednisolone